K. Y. Mitrofanov

Susceptibility of monocytes to activation correlates with atherogenic mitochondrial DNA mutations.

A. Orekhov, M. Kubekina, I. Sobenin, 2015, Experimental and molecular pathology.

Quantitative Assessment of Heteroplasmy of Mitochondrial Genome: Perspectives in Diagnostics and Methodological Pitfalls

A. Orekhov, Y. Bobryshev, I. Sobenin, 2014, BioMed research international.

Mutations of mitochondrial DNA in atherosclerosis and atherosclerosis-related diseases.

A. Orekhov, I. Sobenin, V. Sinyov, 2015, Current pharmaceutical design.

Analysis of mitochondrial DNA heteroplasmic mutations A1555G, C3256T, T3336C, С5178А, G12315A, G13513A, G14459A, G14846А and G15059A in CHD patients with the history of myocardial infarction.

A. Orekhov, Y. Bobryshev, A. Zhelankin, 2016, Experimental and molecular pathology.

A Method for Measuring the Heteroplasmy Level of Mitochondrial DNA Mutations

A. Orekhov, I. Sobenin, Z. Khasanova, 2018, Russian Journal of Genetics.

Analysis of mitochondrial DNA heteroplasmic mutations A1555G, C3256T, T3336C, С5178А, G12315A, G13513A, G14459A, G14846А and G15059A in CHD patients with the history of myocardial infarction.

A. Orekhov, Y. Bobryshev, A. Zhelankin, 2016, Experimental and molecular pathology.